Patents by Inventor Anett Stephan

Anett Stephan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BACTERIOCINS FOR CONTROL OF SALMONELLA ENTERICA
    Publication number: 20230406892
    Abstract: The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.
    Type: Application
    Filed: September 21, 2020
    Publication date: December 21, 2023
    Inventors: Simone Hahn, Tobias Schneider, Anett Stephan, Steve Schulz, Anatoli Giritch, Yuri Gleba, Heike Prochaska
  • PRODUCTS FOR ORAL CONSUMPTION WITH REDUCED SUGAR CONTENT
    Publication number: 20230270145
    Abstract: A product for oral consumption, such as a food, comprising at least one thaumatin selected from the group consisting of thaumatin I and thaumatin II and at least one sugar selected from the group consisting of sucrose, glucose, and fructose in a mass ratio of said thaumatin:to said sugar of from 1:2,000 to 1:80,000.
    Type: Application
    Filed: June 29, 2021
    Publication date: August 31, 2023
    Inventors: Anett Stephan, Simone Hahn-Löbmann, Heike Prochaska, Anatoli Giritch, Yuri Gleba
  • Bacteriocins for Control of Salmonella enterica
    Publication number: 20220073575
    Abstract: The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.
    Type: Application
    Filed: September 21, 2021
    Publication date: March 10, 2022
    Inventors: Simone Hahn, Tobias Schneider, Anett Stephan, Steve Schulz, Anatoli Giritch, Yuri Gleba
  • Bacteriocins for control of
    Patent number: 11161886
    Abstract: The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: November 2, 2021
    Assignee: NOMAD BIOSCIENCE GMBH
    Inventors: Simone Hahn, Tobias Schneider, Anett Stephan, Steve Schulz, Anatoli Giritch, Yuri Gleba
  • Bacteriocins for control of Salmonella enterica
    Publication number: 20200010517
    Abstract: The present invention relates to bacteriocins for control of Salmonella enterica (salmocins). The bacteriocins are derived from Salmonella. The salmocins can be expressed in plants and can be used in a method of preventing or reducing infection or contamination of an object with Salmonella.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 9, 2020
    Inventors: Simone Hahn, Tobias Schneider, Anett Stephan, Steve Schulz, Anatoli Giritch, Yuri Gleba
  • Colicins for the control of EHEC
    Patent number: 10201168
    Abstract: The invention provides a method of preventing or reducing contamination of an object such as food with enterohaemorrhagic E. coli (EHEC), comprising contacting said object with colicin M or a derivative thereof.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: February 12, 2019
    Assignee: Nomad Bioscience GmbH
    Inventors: Anatoli Giritch, Simone Hahn, Steve Schulz, Anett Stephan, Yuri Gleba, Franziska Jarczowski
  • Colicins for the control of EHEC
    Publication number: 20160345599
    Abstract: The invention provides a method of preventing or reducing contamination of an object such as food with enterohaemorrhagic E. coli (EHEC), comprising contacting said object with colicin M or a derivative thereof.
    Type: Application
    Filed: May 2, 2016
    Publication date: December 1, 2016
    Inventors: Anatoli Giritch, Simone Hahn, Steve Schulz, Anett Stephan, Yuri Gleba
  • Mouse models carrying a knock-out mutation of the QPCTL-gene
    Patent number: 9277737
    Abstract: A knock-out non-human animal, in particular a mouse, carrying a QPCTL knock-out mutation. Additionally, respective cells and cell lines and methods and compositions for evaluating agents that affect QPCTL, for use in compositions for the treatment of QPCTL-related diseases are disclosed.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: March 8, 2016
    Assignee: PROBIODRUG AG
    Inventors: Hans-Ulrich Demuth, Anett Stephan, Birgit Koch, Holger Cynis, Stephan Schilling, Reinhard Sedlmeier, Sigrid Graubner
  • Crystal structure of isoglutaminyl cyclase
    Patent number: 8741614
    Abstract: A crystal comprising human isoglutaminyl cyclase having a characterized space group of P1211 and unit cell dimensions of +/?5% of a=126.51 ?, b=109.68 ?, c=159.53 ?, ?=90.0°, ?=104.9° and ?=90.0°.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: June 3, 2014
    Assignee: Probiodrug AG
    Inventors: Anett Stephan, Stephan Schilling, Jens-Ulrich Rahfeld, Michael Wermann, Christoph Parthier, Hans-Ulrich Demuth, David Ruiz-Carillo, Milton T. Stubbs
  • CRYSTAL STRUCTURE OF ISOGLUTAMINYL CYCLASE
    Publication number: 20120108449
    Abstract: A crystal comprising human isoglutaminyl cyclase having a characterised space group of P1211 and unit cell dimensions of +/?5% of a=126.51 ?, b=109.68 ?, c=159.53 ?, ?=90.0°, ?=104.9° and ?=90.0°.
    Type: Application
    Filed: October 28, 2011
    Publication date: May 3, 2012
    Applicant: PROBIODRUG AG
    Inventors: Anett Stephan, Stephan Schilling, Jens-Ulrich Rahfeld, Michael Wermann, Christoph Parthier, Hans-Ulrich Demuth, David Ruiz-Carillo, Milton T. Stubbs
  • MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE QPCTL-GENE
    Publication number: 20100299766
    Abstract: A knock-out non-human animal, in particular a mouse, carrying a QPCTL knock-out mutation. Additionally, respective cells and cell lines and methods and compositions for evaluating agents that affect QPCTL, for use in compositions for the treatment of QPCTL-related diseases are disclosed.
    Type: Application
    Filed: May 19, 2010
    Publication date: November 25, 2010
    Applicant: PROBIODRUG AG
    Inventors: Hans-Ulrich Demuth, Anett Stephan, Birgit Koch, Holger Cynis, Stephan Schilling, Reinhard Sedlmeier, Sigrid Graubner